Protected, High-Margin Medicines in the U.S., EXPAREL® and ZILRETTA®, and Expects to Expand the Products' Reach Across ...
Viatris is acquiring Pacira BioSciences for $1.65 billion in cash, adding non-opioid pain therapies Exparel and Zilretta.
Pacira BioSciences, Inc. (NASDAQ: PCRX), the industry leader in its commitment to deliver innovative, non-opioid pain therapies to transform the lives of patients, and Caregiver Action Network (CAN), ...
A research team led by Yang Hee-seok, a professor in the biomedical systems program at Dankook University, has developed a biodegradable nerve regeneration mate ...
Nearly two-thirds (63%) of Americans with an overdue tax bill owe the IRS at least $10,000, according to a 2026 survey by LendEDU, while more than 10% owe $100,000 or more. A tax relief company can ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results